Metric Finance
LearnFAQ
LearnFAQ

Learn / ARWR

NASDAQ: ARWR

Arrowhead Pharmaceuticals (ARWR) stock, explained like you're 5

Arrowhead Pharmaceuticals trades on the Nasdaq under the ticker ARWR. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 8.9 billion dollars.

Ticker
ARWR
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 8.9 billion dollars

Is Arrowhead Pharmaceuticals a small, medium or large cap company?

No. Arrowhead Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 8.9 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Arrowhead Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ARWR stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • ARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near (Stocktwits)
  • Arrowhead Pharmaceuticals (ARWR) Reports Fresh ARO MAPT Data, Is The Stock Still Cheap? (Yahoo Finance)
  • Why is Arrowhead Pharmaceuticals stock surging today? (Investing.com)
  • Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results (Arrowhead Pharmaceuticals, Inc.)
  • What Arrowhead Pharmaceuticals Doubters Missed (Simply Wall Street)

Follow ARWR in your daily brief

Each trading day at 5 PM ET we post what happened to Arrowhead Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ARWR

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Arrowhead Pharmaceuticals stock

What does Arrowhead Pharmaceuticals do?

Arrowhead Pharmaceuticals trades on the Nasdaq under the ticker ARWR. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 8.9 billion dollars.

What is the ticker symbol for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals trades under the ticker ARWR on the Nasdaq.

What is Arrowhead Pharmaceuticals's market cap?

Arrowhead Pharmaceuticals is a mid cap stock with a market cap of about 8.9 billion dollars.

How does Arrowhead Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ARWR stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ARWR stock every day?

Add ARWR to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ARWR daily

A free brief on Arrowhead Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare ARWR: ARWR vs NVS, ARWR vs AZN, ARWR vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed